- Home
- CHRS vs BEEP Comparison
CHRS vs BEEP Comparison
Compare CHRS & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHRS
- BEEP
- Stock Information
- Founded
- CHRS 2010
- BEEP 2015
- Country
- CHRS United States
- BEEP United States
- Employees
- CHRS N/A
- BEEP N/A
- Industry
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- BEEP Blank Checks
- Sector
- CHRS Health Care
- BEEP Finance
- Exchange
- CHRS Nasdaq
- BEEP Nasdaq
- Market Cap
- CHRS 84.2M
- BEEP 162.0M
- IPO Year
- CHRS 2014
- BEEP N/A
- Fundamental
- Price
- CHRS $0.88
- BEEP $3.69
- Analyst Decision
- CHRS Buy
- BEEP Strong Buy
- Analyst Count
- CHRS 3
- BEEP 2
- Target Price
- CHRS $4.68
- BEEP $6.75
- AVG Volume (30 Days)
- CHRS 1.3M
- BEEP 122.4K
- Earning Date
- CHRS 08-07-2025
- BEEP 08-12-2025
- Dividend Yield
- CHRS N/A
- BEEP N/A
- EPS Growth
- CHRS N/A
- BEEP N/A
- EPS
- CHRS N/A
- BEEP N/A
- Revenue
- CHRS $272,251,000.00
- BEEP $36,416,000.00
- Revenue This Year
- CHRS N/A
- BEEP $5.22
- Revenue Next Year
- CHRS $99.43
- BEEP $5.13
- P/E Ratio
- CHRS N/A
- BEEP N/A
- Revenue Growth
- CHRS 19.87
- BEEP 13.81
- 52 Week Low
- CHRS $0.66
- BEEP $2.48
- 52 Week High
- CHRS $2.43
- BEEP $4.86
- Technical
- Relative Strength Index (RSI)
- CHRS 55.66
- BEEP 33.42
- Support Level
- CHRS $0.82
- BEEP $3.66
- Resistance Level
- CHRS $0.94
- BEEP $4.24
- Average True Range (ATR)
- CHRS 0.06
- BEEP 0.24
- MACD
- CHRS 0.01
- BEEP -0.09
- Stochastic Oscillator
- CHRS 67.00
- BEEP 2.97
About CHRS Coherus BioSciences Inc.
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.